Smith & Nephew Plc
23 March 2000
DISCUSSIONS WITH BEIERSDORF
Smith & Nephew plc, the global medical device company,
announces that it is in discussions with Beiersdorf AG
regarding possible co-operation in certain complementary areas
of their businesses. The scope of the discussions involves
possible joint ventures and transfers of parts of the
businesses concerned, consistent with Smith & Nephew's
strategy of reshaping its overall business. There can be no
certainty that the discussions will be concluded successfully
and a further announcement is not expected until late in the
second quarter of this year.
Enquiries:
David Yates Tel: +44 (0) 171 831 3113
Financial Dynamics Fax: +44 (0) 171 831 6341
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.